已收盘 01-10 16:00:00 美东时间
0.000
0.00%
6月23日,量子物理、AI与机器人药物及新材料研发平台晶泰科技(02228)宣布与美国化学生物学泰斗Gregory Verdine创立的DoveTree LL...
06-24 11:18
Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary fibrosis (IPF) in the first half of 2025 Posi...
04-08 04:17
Rebrand to Rein Therapeutics is representative of the Company's sole focus in developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets C...
01-11 00:30
Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients.
2024-11-14 02:04
Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option ...
2024-10-31 19:30
北京时间2024年10月23日02时38分,Aileron Therapeutics, Inc.(ALRN.us)股票出现波动,股价急速上涨5.04%。截至发稿...
2024-10-23 02:38
AUSTIN, Texas, Aug. 19, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Ailer...
2024-08-20 04:05
Aileron Therapeutics, Inc. Q2 Operating Expenses USD 9.039 Million
2024-08-15 06:05
Aileron Therapeutics, Inc. Q2 Basic EPS USD -0.45
2024-08-15 06:05
Aileron Therapeutics, Inc. Q2 Net Income USD -8.942 Million
2024-08-15 06:05